These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 7208504)

  • 1. Azotemic osteodystrophy - indications for intervention.
    Ritz E
    Prog Biochem Pharmacol; 1980; 17():251-8. PubMed ID: 7208504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indications for parathyroidectomy in advanced renal disease.
    Buck BA; Robertson RD
    Surg Gynecol Obstet; 1971 Aug; 133(2):218-24. PubMed ID: 4935588
    [No Abstract]   [Full Text] [Related]  

  • 4. Review of dialysate calcium concentration in hemodialysis.
    Toussaint N; Cooney P; Kerr PG
    Hemodial Int; 2006 Oct; 10(4):326-37. PubMed ID: 17014507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caclium, phosphorus, and bone in renal disease and transplantation.
    Bricker NS; Slatopolsky E; Reiss E; Avioli LV
    Arch Intern Med; 1969 May; 123(5):543-53. PubMed ID: 4888973
    [No Abstract]   [Full Text] [Related]  

  • 6. [Disorders of calcium metabolism in kidney failure].
    Ritz E; Krempien B; Andrassy K
    Med Klin; 1972 Sep; 67(36):1129-32. PubMed ID: 4561354
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of uremic osteopathy. Effects of vitamin D metabolites and vitamin D analogs in chronic uremia and experimental renal insufficiency].
    von Herrath D; Kraft D; Schaefer K; Krempien B
    MMW Munch Med Wochenschr; 1974 Sep; 116(37):1573-8. PubMed ID: 4374654
    [No Abstract]   [Full Text] [Related]  

  • 8. Glomerular (azotemic) osteodystrophy.
    Kyle LH
    Annu Rev Med; 1969; 20():259-76. PubMed ID: 4307817
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current problems of azotemic bone diseases].
    Schaefer K; Opitz A
    Dtsch Med Wochenschr; 1970 Jan; 95(2):84-8. PubMed ID: 4902985
    [No Abstract]   [Full Text] [Related]  

  • 10. Different routes bridging calcium in Japanese hemodialysis patients.
    Hamano T; Fujii N; Ito T; Imai E
    Ther Apher Dial; 2005 Feb; 9(1):32-8. PubMed ID: 15828903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium and phosphorus metabolism in chronic uremia.
    Fiaschi E; Mioni G; Maschio G; D'Angelo A; Ossi E
    Nephron; 1975; 14(2):163-80. PubMed ID: 1093055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reappraisal of 2003 NKF-K/DOQI guidelines for management of hyperparathyroidism in chronic kidney disease patients.
    Monge M; Shahapuni I; Oprisiu R; El Esper N; Morinière P; Massy Z; Choukroun G; Fournier A
    Nat Clin Pract Nephrol; 2006 Jun; 2(6):326-36. PubMed ID: 16932454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroidectomy. Treatment for secondary hyperparathyroidism and azotemic osteodystrophy.
    Berens JJ; Potter DJ; Nickas GM
    Arch Surg; 1970 Apr; 100(4):338-42. PubMed ID: 5417157
    [No Abstract]   [Full Text] [Related]  

  • 14. [Secondary hyperparathyroidism and tertiary hyperparathyroidism chronic renal failure, uremia].
    Morio K; Koide K
    Nihon Rinsho; 1995 Apr; 53(4):958-64. PubMed ID: 7752492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disorders of calcium and bone metabolism in chronic renal failure.
    Avioli LV
    Mod Treat; 1970 May; 7(3):675-85. PubMed ID: 4920810
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chronic kidney disease (CKD) and bone. Management of chronic kidney disease-mineral and bone disorder in peritoneal dialysis patients].
    Yaginuma T; Yamamoto H
    Clin Calcium; 2009 Apr; 19(4):508-13. PubMed ID: 19329829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of surgical parathyroidectomy for secondary hyperparathyroidism in renal dialysis patients in Qatar.
    Rashed A; Fahmi M; ElSayed M; Aboud O; Asim M
    Transplant Proc; 2004; 36(6):1815-7. PubMed ID: 15350484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary hyperparathyroidism in chronic renal failure. The clinical spectrum in uremia, during hemodialysis, and after renal transplantation.
    Massry SG; Coburn JW; Popovtzer MM; Shinaberger JH; Maxwell MH; Kleeman CR
    Arch Intern Med; 1969 Oct; 124(4):431-41. PubMed ID: 4901739
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of lowering dialysate calcium concentration on serum bone turnover markers in hemodialysis patients.
    Hamano T; Oseto S; Fujii N; Ito T; Katayama M; Horio M; Imai E; Hori M
    Bone; 2005 May; 36(5):909-16. PubMed ID: 15794928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal osteodystrophy in end-stage renal failure.
    Nortman DF; Coburn JW
    Postgrad Med; 1978 Nov; 64(5):123-30. PubMed ID: 714829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.